The Prolactin signaling pathway, targeted by ESR1, activates pathways involved in the inflammatory response including the KEGG secondary MAPK pathway and PI3K pathway and is also involved in the secondary KEGG asthma NF-κB signaling pathway; with ESR1 again acting downstream (KEGG). Here, PRL is linked to asthma.